Your browser doesn't support javascript.
loading
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab.
Aryanian, Zeinab; Tahooneban, Amir; Balighi, Kamran; Daneshpazhooh, Maryam; Mahmoudi, Hamidreza; Soori, Tahereh; Mohseniafshar, Zeinab; Tavakolpour, Soheil; Hatami, Parvaneh.
Afiliação
  • Aryanian Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Tahooneban A; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran.
  • Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahmoudi H; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Soori T; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohseniafshar Z; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Tavakolpour S; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Hatami P; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Dermatol Ther ; 35(11): e15783, 2022 11.
Article em En | MEDLINE | ID: mdl-36001617

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Pênfigo / Hepatite B Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Pênfigo / Hepatite B Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article